Cytokeratin 20 positive cells in blood of colorectal cancer patients as an unfavorable prognostic marker

Colorectal carcinomas in 2014: The search for powerful prognostic markers is still on the go!

(2017) Julien Coget et al.   Cancer Biomarkers

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer

(2016) Piero Dalerba et al.   NEW ENGLAND JOURNAL OF MEDICINE

Unknown

(2016)   CA-A CANCER JOURNAL FOR CLINICIANS

Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer

(2015) Xuanzhang Huang et al.   BMC CANCER

Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer

(2014) Aalok Kumar et al.   CANCER

Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay

(2014) Wael Harb et al.   Translational Oncology

Postoperative Detection of Circulating Tumor Cells Predicts Tumor Recurrence in Colorectal Cancer Patients

(2013) Gennaro Galizia et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Next-Generation Stool DNA Test Accurately Detects Colorectal Cancer and Large Adenomas

(2011) David A. Ahlquist et al.   GASTROENTEROLOGY

Persistent Presence of Postoperative Circulating Tumor Cells is a Poor Prognostic Factor for Patients with Stage I–III Colorectal Cancer after Curative Resection

(2008) Yih-Huei Uen et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic Relevance of Occult Nodal Micrometastases and Circulating Tumor Cells in Colorectal Cancer in a Prospective Multicenter Trial

(2008) K. Koyanagi et al.   CLINICAL CANCER RESEARCH